Time(GMT+8)

Topic

13:00-14:20

Frontier Session 1- Dialogues Between Imaging Specialists and Physicians

Postgraduate Course 1 - New Drug Development and Cure of Hepatitis B 1

14:20-14:50

Break

Postgraduate Course 2 - New Drug Development and Cure of Hepatitis B 2

14:50-16:00

Frontier Session 2 - Imaging Technology: Diagnosis and Monitoring

16:00-17:30

Frontier Session 3 - Kick of Project from Imaging MRI to aMap Plus for Screening HCC

Concurrent Session 1 - Basic to Translational Science in Liver Diseases

17:30-19:00

State-of-the-art 1

19:00 - 20:00

Young Investigator Award Session 1

October 22 (SAT)

Time(GMT+8)

Topic

08:30-08:45

Opening Ceremony

08:45-10:35

State-of-the-art 2

10:15-11:30

Frontier Session 4- Hot Spots in Hepatology

11:30-13:00

Satellite Symposium

13:00-13:30

Break

13:30-15:00

Concurrent Session 2  - Portal Hypertension: Screening and Surveillance

Concurrent Session 3 - Epidemiology of liver diseases

15:00-16:30

Concurrent Session 4 - DSA-guided Treatments in Variceal Bleeding

Concurrent Session 5 - HCC Screening and Very Early Diagnosis

16:30-18:00

Special Session 1 - Liver Failure: Diagnosis and Therapeutics

19:00 - 20:00

Young Investigator Award Session 2

October 23(SUN)

Time(GMT+8)

Topic

08:30-10:30

State-of-the-art 3

10:30-12:00

Special Session 2- Multidisciplinary Approach in HCC

12:00-12:15

Awards and closing ceremony

October 21 (FRI)

International Conference Hall

Time(GMT+8)

Topic

Speaker

Region

13:00 - 14:50

Frontier Session 1 - Dialogues Between Imaging Specialists and Physicians

前沿论坛1 - 影像专家和医生之间的对话

Moderator:

Jinlin HOU, Yikai XU, Jin Mo YANG

主持人:

侯金林, 许乙凯, Jin Mo YANG

Coordinator：

Yujun TANG

13:00 - 13:20

Fusion imaging combined with

CEUS for diagnosis and treatment of liver cancer

Hong YANG

Nanning

融合影像与CEUS在肝癌诊断和治疗中的应用

杨红

Nanning

13:20 - 13:40

The value of Gd-EOB-DTPA-enhanced MRI for HCC screening

Enming CUI

Jiangmen

Gd-EOB-DTPA增强MRI在肝癌筛查中的价值

崔恩铭

Jiangmen

13:40 - 13:50

Case study

Kunyuan WANG

Guangzhou

病例研究

王坤远

Guangzhou

13:50 - 14:00

Case study

Cheng ZHANG

Guangzhou

病例研究

张乘

Guangzhou

14:00 - 14:20

Discussion

讨论

14:20 - 14:50

Break

14:50 - 16:00

Frontier Session 2 - Imaging Technology: Diagnosis and Monitoring

前沿论坛2 - 影像技术：诊断和监测

Moderator:

Minghua ZHENG, Yingli HE, Kai LI

主持人:

郑明华, 何英利, 李凯

Coordinator:

Beiling LI（黎倍伶）, Changze HONG

14:50 - 15:10

AI digital pathology in liver diseases

Nikolai NAOUMOV

London

肝脏疾病中的人工智能数字病理学

Nikolai NAOUMOV

London

15:10 - 15:30

qFibrosis for NASH

Yan WANG

Guangzhou

非酒精性脂肪肝炎的qFibrosis

汪艳

Guangzhou

15:30 - 15:50

Detection and quantification: AI and imaging

Hanry YU

Singapore

检测和量化：人工智能和影像

Hanry YU

Singapore

15:50 - 16:00

Discussion

讨论

16:00 - 17:30

Frontier Session 3 - Kick of Project from Imaging MRI to aMap Plus for Screening HCC

前沿论坛3 - 从MRI影像到aMap Plus的肝癌筛查项目启动

Moderator:

Yikai XU, Jinlin HOU, Masao OMATA

主持人:

许乙凯, 侯金林, Masao OMATA

Coordinator:

Yujun TANG

16:00 - 16:20

aMap Plus for Screening HCC

Jinlin HOU

Guangzhou

aMap Plus的肝癌筛查

侯金林

Guangzhou

16:20-16:30

Project Launching Ceremony

项目启动仪式

16:30 - 16:50

Academic lecture：A review of recent Gadoxetic acid MRI literature

Jing WANG

Guangzhou

学术讲座：钆塞酸二纳MRI近期文献综述回顾

王劲

Guangzhou

16:50 - 17:30

Discussion and Conclusion

讨论与总结

17:30 - 19:00

State - of - the - art 1

前沿报告1

Moderator:

Jinjun CHEN, Min ZHENG, Barjesh C. SHARMA

主持人:

陈金军, 郑敏, Barjesh C. SHARMA

Coordinator:

Haiyu WANG

17:30 - 17:55

ACLF therapy updates: immunne modulation

Rajiv JALAN

London

ACLF治疗更新：免疫调节

Rajiv JALAN

London

17:55 - 18:20

Managing cirrhosis related porto-systemic shunts: All retrograde and antegrade shunt obliteration

Amar MUKUND

New Delhi

肝硬化相关门体分流的处理：所有逆行和顺行分流闭塞

Amar MUKUND

New Delhi

18:20 - 18:45

Novel low-avidity glypican-3 specific CARTs against hepatocellular carcinoma

Yukai HE

Augusta

抗肝细胞癌的新型低亲和力glypican-3特异性CART

何玉凯

Augusta

18:45 - 19:00

Discussion

讨论

19:00 - 20:00

Young Investigator Award Session 1

青年研究者论坛1

Moderator:

Masao OMATA, Jian SUN, Yongyin LI

主持人:

Masao OMATA, 孙剑, 李咏茵

Coordinator:

Haiyu WANG

19:00 - 19:15

Development and Validation of a Hepatic Vascular Geometrical Model for Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)

Yifei HUANG

Nanjing

肝脏血管几何模型无创诊断肝硬化门静脉高压（CHESS1802）

黄义飞

Nanjing

19:15 - 19:30

Establishment and validation of a quick bedside test with number connection test A and animal and vegetable naming test for minimal hepatic encephalopathy

Qiuyu CHENG

Wuhan

轻度肝性脑病快速床旁试验与数字连接试验a和动植物命名试验的建立与验证

程秋瑜

Wuhan

19:30 - 19:45

Post-TIPS Short-term Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction: An Randomised Controlled Trial

Xiaoze WANG

Chengdu

TIPS后短期低分子肝素抗凝对分流道通畅性的影响：一项随机对照试验

王小泽

Chengdu

19:45 - 20:00

Consecutive Baveno VII criteria can rule out high-risk varices excellently in patients with cirrhosis

Haiyu WANG

Guangzhou

连续的Baveno VII标准可以很好地排除肝硬化患者的高危静脉曲张

王海玉

Guangzhou

October 21 (FRI)

Lecture Hall

Time(GMT+8)

Topic

Speaker

Region

13:00 - 14:30

Postgraduate Course 1 - New Drug Development and Cure of Hepatitis B 1

继续教育课程1 - 乙型肝炎新药研发和治疗1

Moderator:

Qing XIE, Manoj K SHARMA

主持人:

谢青, Manoj K SHARMA

Coordinator:

Xieer LIANG

13:00 - 13:20

Endpoints of clinical trials in chronic hepatitis B

Henry L.Y. CHAN

Hong Kong

慢性乙型肝炎临床试验的终点

陈力元

Hong Kong

13:20 - 13:40

Who may be curable? Subjects of clinical trials in chronic hepatitis B

Jidong JIA

Beijing

谁可以被治愈？慢性乙型肝炎临床试验受试者

贾继东

Beijing

13:40 - 14:00

New targets for hepatitis B cure

Jinlin HOU

Guangzhou

乙型肝炎治疗的新靶点

侯金林

Guangzhou

14:00 - 14:20

Therapeutic strategies targeting innate and adaptive immunity and immune therapy modulation for hepatitis B

Qin NING

Wuhan

针对乙型肝炎固有免疫和适应性免疫的治疗策略及免疫治疗调节

宁琴

Wuhan

14:20 - 14:30

Discussion

讨论

14:30 - 15:40

Postgraduate Course 2 - New Drug Development and Cure of Hepatitis B 2

继续教育课程2 - 乙型肝炎新药研发和治疗2

Moderator:

Qin NING, Rino GANI

主持人:

宁琴, Rino GANI

Coordinator:

Xieer LIANG

14:30 - 14:50

Entry inhibitors

Wenhui LI

Beijing

进入抑制剂

李文辉

Beijing

14:50 - 15:10

Does peginterferon have a role in HBV cure programs

Grace WONG

Hong Kong

聚乙二醇干扰素在HBV治疗计划中有作用吗？

黄丽虹

Hong Kong

15:10 - 15:30

Targeting cccDNA

Fengmin LU

Beijing

靶向cccDNA

鲁凤民

Beijing

15:30 - 15:40

Discussion

讨论

15:40 - 17:10

Concurrent Session 1 - Basic to Translational Science in Liver Diseases

平行会议1-肝病转化科学基础

Moderator:

Jia-Horng KAO, Sha WU,  Wei ZHU

主持人:

高嘉宏, 吴砂,  朱伟

Coordinator:

Wei ZHU

15:40 - 16:00

B cells/antibodies in the progression and the treatment outcome of liver cancer

Dongming KUANG

Guangzhou

肝癌进展和治疗结果中的B细胞/抗体

邝栋明

Guangzhou

16:00 - 16:20

Target HBV to prevent and treat HCC - From sequence to clinical efficacy

Ke ZHANG

Shanghai

靶向HBV防治HCC——从序列到临床疗效

张柯

Shanghai

16:20 - 16:40

Gut microbiota and liver injury

Peng CHEN

Guangzhou

肠道菌群与肝损伤

陈鹏

Guangzhou

16:40 - 17:00

Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease

Minghua ZHENG

Wenzhou

非酒精性脂肪肝非肥胖患者及高危患者的生活方式干预

郑明华

Wenzhou

17:00 - 17:10

Discussion

讨论

Time(GMT+8)

Topic

Speaker

Region

08:30 - 08:45

Opening Ceremony

开幕式

Moderator:

George LAU, Jidong JIA, Jinlin HOU

主持人:

廖家杰, 贾继东, 侯金林

Coordinator:

Beiling LI, Changze HONG

08:30 - 08:35

Opening Remark 1

Shiv K.SARIN

New Delhi

开幕致辞1

Shiv K.SARIN

New Delhi

08:35 - 08:40

Opening Remark 2

Masao OMATA

Tokyo

开幕致辞2

Masao OMATA

Tokyo

08:40 - 08:45

Opening Remark 3

Jinjun CHEN

Guangzhou

开幕致辞3

陈金军

Guangzhou

08:45 - 10:15

State - of - the - art 2

前沿报告2

Moderator:

Osamu YOKOSUKA, Lai WEI, Xiaoping TANG

主持人:

Osamu YOKOSUKA, 魏来,  唐小平

Coordinator:

Beiling LI, Changze HONG

08:45 - 09:10

Management of Budd-Chiari syndrome: Beyond Baveno VII

Shiv K.SARIN

New Delhi

Budd-Chiari综合征的治疗：Baveno VII之外

Shiv K.SARIN

New Delhi

09:10 - 09:35

Mesenchymal stem cell therapy for ACLF and DLC patients

Fu-Sheng WANG

Beijing

间充质干细胞治疗慢加急性肝衰竭及失代偿肝硬化患者

王福生

Beijing

09:35 - 10:00

Advances in treatment of liver cancer

George LAU

Hong Kong

肝癌治疗进展

廖家杰

Hong Kong

10:00 - 10:15

Discussion

讨论

10:15 - 11:30

Frontier Session 4 - Hot Spots in Hepatology

前沿论坛4 - 肝病学热点

Moderator:

Tawesak TANWANDEE, Jinjun CHEN

主持人:

Tawesak TANWANDEE, 陈金军

Coordinator:

Rong FAN, Hualan WU

10:15 - 10:35

Serum HBV RNA: New biomarker for the management of hepatitis B

Jian SUN

Guangzhou

血清HBV RNA：乙型肝炎治疗的新生物标志物

孙剑

Guangzhou

10:35 - 10:55

Spatio-temporal dynamics of gene regulation during liver regeneration

Miguel A. ESTEBAN

Sevilla

肝再生过程中基因调控的时空动态

Miguel A. ESTEBAN

Sevilla

10:55 - 11:20

Special lecture：Pay attention to the change of scientific research paradigm of complex diseases

Hongyang WANG

Shanghai

重视复杂疾病的科研范式变化

王红阳

Shanghai

11:20- 11:30

Discussion

讨论

11:30 - 12:00

Satellite Symposium 1: Optimized screening and diagnosis of chronic hepatitis B-related HCC

Jian SUN

Guangzhou

学术研讨会1: 慢性乙型肝炎相关肝癌的优化筛查和诊断

孙剑

Guangzhou

Moderator: Jinlin HOU

主持人: 侯金林

12:00- 12:30

Satellite Symposium 2: The value of three hepatocellular carcinoma (AFP/AFP-L3%/DCP) in hepatocellular carcinoma management

Jinlin HOU

Guangzhou

学术研讨会2: 三种肝细胞癌（AFP/AFP-L3%/DCP）在肝细胞癌管理中的价值

侯金林

Guangzhou

12:30 - 12:50

Satellite Symposium 3: Camrelizumab plus rivoceranib vs. sorafenib as first-line therapy for unresectable hepatocellular carcinoma :a  randomized,phase 3 trial

Ming ZHAO

Guangzhou

卫星专题讨论会3: Camrelizumab联合利沃西拉尼与索拉非尼作为不能切除的肝细胞癌一线治疗的比较：一项随机、3期试验

赵明

Guangzhou

12:50- 13:00

Satellite Symposium 4: Application of Barty Medical high pressure PTA balloon dilatation catheter(Ultra wanty) in TIPS

Hui LI

Guangzhou

学术研讨会4: 巴泰高压球囊之TIPS术式应用

李晖

Guangzhou

13:00 - 13:30

Break

13:30 - 15:00

Concurrent Session 2 - Portal Hypertension: Screening and Surveillance

平行会议2 - 门静脉高压: 筛查和监测

Moderator:

A. Kadir DOKMECI, Huiguo DING, Huadong YAN

主持人:

A. Kadir DOKMECI, 丁惠国, 颜华东

Coordinator:

Haiyu WANG

13:30 - 13:50

Baveno VII-Liver stiffness in cACLD and portal hypertension

Joan GENESCA

Barcelona

Baveno VII- cACLD合并门静脉高压的肝脏硬度

Joan GENESCA

Barcelona

13:50 - 14:10

Portal hyperension regression: From evidence to consensus

Hong YOU

Beijing

门静脉高压的消退：从证据到共识

尤红

Beijing

14:10 - 14:30

Clinical application of EGD-EUS-guide liver biopsy and measurement of portosystemic pressure gradient

Ke-Qin HU

Los Angeles

EGD-EUS引导肝活检及门静脉系统压力梯度测定的临床应用

Ke-Qin HU

Los Angeles

14:30 - 14:50

Current status and prospect of clinical research on portal hypertension in China

Xiaolong QI

Nanjing

我国门静脉高压临床研究现状与展望

祁小龙

Nanjing

14:50 - 15:00

Discussion

讨论

15:00 - 16:30

Concurrent Session 4 - DSA-guided Treatments in Variceal Bleeding

平行会议4 - DSA指导下静脉曲张出血的治疗

Moderator:

Diana A. PAYAWAL, Li YANG

主持人:

Diana A. PAYAWAL, 杨丽

Coordinator:

Hui LI（李晖）, Xiaofeng ZHANG

15:00 - 15:20

TIPS for Treatment of PA-HSOS

Yuzheng ZHUGE

Nanjing

PA-HSOS的TIPS治疗

诸葛宇征

Nanjing

15:20 - 15:40

Hepatic encephalopathy (HE) balloon-occluded retrograde transvenous obliteration (BRTO)

Guohong HAN

Xian

经球囊导管阻塞下逆行静脉栓塞术（BRTO）治疗肝性脑病（HE）

韩国宏

Xian

15:40 - 16:00

Progress in the diagnosis and treatment of portal hypertensive enteropathy

Changqing YANG

Shanghai

门脉高压性肠病诊治进展

杨长青

Shanghai

16:00 - 16:20

Image-guided therapy for acute variceal bleeding

Xuefeng LUO

Chengdu

影像介导的急性静脉曲张出血治疗

罗薛峰

Chengdu

16:20 - 16:30

Discussion

讨论

16:30 - 18:00

Special Session 1 - Liver Failure: Diagnosis and Therapeutics

特别会议1 - 肝衰竭：诊断和治疗

Moderator:

Ian Homer Y. Cua, Yu CHEN, Yu SHI, Jinhang GAO

主持人:

Ian Homer Y. CUA, 陈煜, 施毓, 高锦航

Coordinator:

Beiling LI, Changze HONG

16:30 - 16:50

ACLF: How prior for liver transplantation

Jun LI

Hangzhou

慢加急性肝衰竭：肝脏移植的优先顺序

李君

Hangzhou

16:50 - 17:10

ACLF therapy: Organ supports

Jinjun CHEN

Guangzhou

慢加急性肝衰竭的器官支持治疗

陈金军

Guangzhou

17:10 - 17:30

liver regeneration, the treatment of liver failure

Jinhua HU

Beijing

肝衰竭的治疗：肝再生

胡瑾华

Beijing

17:30 - 17:50

Metabolic Biomarkers Significantly Enhance the Prediction of Acute-on-Chronic Liver Failure Prognosis

Hai Li

Shanghai

代谢分子标志物显著提高慢加急性肝衰竭预后的预测作用

李海

Shanghai

17:50 - 18:00

Discussion

讨论

19:00 - 20:00

Young Investigator Award Session 2

青年研究者论坛2

Moderator:

Shiv K.SARIN, Jinjun CHEN, Rong FAN

主持人:

Shiv K.SARIN, 陈金军, 樊蓉

Coordinator:

Haiyu WANG

19:00 - 19:15

Baveno VII algorithm outperformed other models in ruling out high-risk varices in patients with HBV-related cirrhosis

Jiankang SONG

Guangzhou

Baveno VII算法在排除HBV相关性肝硬化患者的高危静脉曲张方面优于其他模型

宋健康

Guangzhou

19:15 - 19:30

Application of aMAP score to assess the risk of hepatocarciongenesis in population ofchronic liver disease in primary hospitals from China

Xin HAO

Guangzhou

aMAP评分在中国基层医院慢性肝病人群肝癌发生风险评估中的应用

郝新

Guangzhou

19:30 - 19:45

Prediction of invasive procedure-related bleeding risk in patients with chronic liver disease and thrombocytopenia: a large cohort study

Hua-xiang Yang

Beijing

伴血小板减少症的慢性肝病患者侵入性操作相关出血风险的预测：一项大型队列研究

杨华湘

Beijing

19:45 - 20:00

Novel Nomogram Based on Contrast Enhanced Computed Tomography to Distinguishing Idiopathic Non-cirrhotic Portal Hypertension from Liver Cirrhosis

Zijin LIU

Beijing

基于增强CT构建的Nomogram模型鉴别非肝硬化门静脉高压

刘子衿

Beijing

13:30 - 15:00

Concurrent Session 3 - Epidemiology of Liver Diseases

平行会议3 - 肝病流行病学

Moderator:

Hui ZHUANG, Fengmin LU, Vincent W.S. WONG

主持人:

庄辉, 鲁凤民, 黄炜燊

Coordinator:

Rong FAN, Hualan WU

13:30 - 13:50

Progress report on hepatitis elimination in China

Xiaofeng LIANG

Beijing

中国消灭肝炎进展报告

梁晓峰

Beijing

13:50 - 14:10

Prevalence and impact of MAFLD in patients with HBV infection

Chun-Jen LIU

Taipei

乙型肝炎病毒感染者中MAFLD的患病率及其影响

刘俊人

Taipei

14:10 - 14:30

Epidemiology and prevention of HCC in ASIA

Hongmei ZENG

Beijing

亚洲肝癌的流行病学和预防

曾红梅

Beijing

14:30 - 14:50

Prevalence and disease burden of HDV infection

Lai WEI

Beijing

HDV感染的流行率和疾病负担

魏来

Beijing

14:50 - 15:00

Discussion

讨论

15:00 - 16:30

Concurrent Session 5 - HCC Screening and Very Early Diagnosis

同期会议5 - 肝癌筛查和早期诊断

Moderator:

Henry L.Y. CHAN, Jinlin HOU

主持人:

陈力元, 侯金林

Coordinator:

Rong FAN, Hualan WU

15:00 - 15:20

Is NAFLD-associated HCC relevant in Asia?

Vincent W.S. WONG

Hong Kong

NAFLD相关性肝癌与亚洲相关吗？

黄炜燊

Hong Kong

15:20 - 15:40

Early Diagnosis & Surveillance for Liver Cancer

Lei CHEN

Shanghai

肝癌的早期诊断与监测

陈磊

Shanghai

15:40 - 16:00

aMAP: A novel risk score for HCC in chronic liver diseases during antiviral era

Rong FAN

Guangzhou

aMAP：抗病毒时代慢性肝病HCC的新风险评分

樊蓉

Guangzhou

16:00 - 16:20

Epidemiology of Non-alcoholic Fatty Liver Disease

Tamoore ARSHAD

Falls Church

非酒精性脂肪性肝病的流行病学

Tamoore ARSHAD

Falls Church

16:20 - 16:30

Discussion

讨论

16:30 - 16:50

Satellite Symposium 4：Standard diagnosis and treatment of hepatitis B

Jie PENG

Guangzhou

学术专题会1：乙肝规范诊疗

彭劼

Guangzhou

October 23(SUN)

International Conference Hall

Time(GMT+8)

Topic

Speaker

Region

08:30 - 10:30

State - of - the - art 3

前沿报告3

Moderator:

Dong Jin SUH, Jinlin HOU

主持人:

Dong Jin SUH, 侯金林

Coordinator:

Haiyu WANG

08:30 - 08:55

Management of upper gastrointestinal bleeding in advanced hepatocellular cancer treated with TKI: Beyond the known frontiers

Yongping YANG

Beijing

TKI治疗晚期肝细胞癌的上消化道出血管理：已知前沿之外

杨永平

Beijing

08:55 - 09:20

Liver endothelial cell heterogeneity and alterations in the pathogenesis of portal hypertension

Yasuko IWAKIRI

New Haven

肝内皮细胞异质性与门脉高压症发病机制的改变

Yasuko IWAKIRI

New Haven

09:20 - 09:45

Adoptive T cell therapy to treat HBV-related hepatocellular carcinoma

Ulrike PROTZER

Munich

过继性T细胞治疗HBV相关性肝癌

Ulrike PROTZER

Munich

09:45 - 10:10

Management of Hepatocellular Carcinoma

Shuichiro SHIINA

Tokyo

肝细胞癌的治疗

Shuichiro SHIINA

Tokyo

10:10 - 10:30

Discussion

讨论

10:30 - 12:00

Special Session 2 - Multidisciplinary Approach in HCC

特别会议2 - 肝癌的多学科方法

Moderator:

Minshan CHEN, Kangshun ZHU

主持人:

陈敏山, 朱康顺

Coordinator:

Yabing GUO, Jinzhang CHEN, Ling DAI

10:30 - 10:50

Medical image-assisted precise treatment of liver cancer

Ming KUANG

Guangzhou

医学图像辅助肝癌精确治疗

匡铭

Guangzhou

10:50 - 11:10

Current Status of Hepatic Arterial Infusion Chemotherapy in the Treatment of ad-HCC in Asian

Ming ZHAO

Guangzhou

亚洲ad-HCC肝动脉灌注化疗的现状

赵明

Guangzhou

11:10 - 11:30

Anatomical thermal ablation as an alternative to surgical resection for subcapsular hepatocellular carcinoma

Kai LI

Guangzhou

解剖热消融替代手术切除包膜下肝癌

李凯

Guangzhou

11:30 - 11:50

Lenvatinib-based systemic combined with local therapy for HCC: the experience of the EHBH

Shuqun CHENG

Shanghai

以Lenvatinib为基础的全身联合局部治疗肝癌：EHBH的经验

程树群

Shanghai

11:50 - 12:00

Discussion

讨论

12:00 - 12:15

Awards and closing ceremony

Masao OMATA, Jinlin HOU

颁奖和闭幕式

Masao OMATA, 侯金林

Moderator:

Jinjun CHEN

陈金军

Coordinator:

Haiyu WANG